Isotretinoin vs doxycycline for skin rash from targeted cancer drugs
Treatments studied
Part of Skin clinical trials.
This trial compares two oral medications, isotretinoin and doxycycline, to treat a specific type of skin rash (acne-like) caused by cancer treatments that target the MAPK pathway. The study aims to find the best way to clear the rash and improve comfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an acne-like rash that is moderate to severe (grade 2, 3, or 4) from your cancer treatment that targets the MAPK pathway.
- If you've taken doxycycline or similar antibiotics for a rash or acne, your last dose was at least 4 weeks ago. If you've taken isotretinoin for any reason, it was at least 6 months ago.
- You are between 12 and 39 years old.
- Your liver function and blood fats (triglycerides) are within safe limits for these drugs.
- You can take pills (gelatin capsules) and are willing to use effective contraception if needed.
- You agree to have your rash photographed for a central dermatology review.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two antibiotic medications (sarecycline and doxycycline) to see which one works better for moderate acne while also being gentler on the bacteria in your gut. Researchers will track how your skin improves and how these drugs affect your digestive system.
This study tests a new cream, ATR04-484, to see if it can help with skin rashes caused by certain cancer medications (EGFR inhibitors, KRAS inhibitors, or MEK inhibitors). If you have a moderate to severe rash on your face or other areas from these drugs, this trial may offer a new way to ease your symptoms.
This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.
This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.
This study gathers opinions from experienced dermatologists to create expert guidelines on using isotretinoin for acne. It does not test a new treatment but aims to improve how isotretinoin is prescribed.
This study compares two doses of an acne pill called isotretinoin to see if a lower dose works as well as the standard dose with fewer side effects. If you have moderate to severe acne, this trial might help you find an effective treatment with less risk of side effects.
Hear when a new Acneiform Drug Eruption trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.